CS
ORTX

Credit Suisse’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Credit Suisse’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,550
Closed -$497K – 4299
2019
Q2 		$497K Buy
+3,550
New +$623K ﹤0.01% 3416
2019
Q1 		– Sell
-1,135
Closed -$179K – 4188
2018
Q4 		$179K Buy
+1,135
New +$169K ﹤0.01% 3693

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Credit Suisse's ORTX Position: Q3 2019 in Review

Credit Suisse sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2019, closing a stake of 3,550 shares — an estimated $497K sold.

Credit Suisse first reported a position in ORTX in Q4 2018 and held it in 2 quarters. The position peaked at $497K in Q2 2019. 62 funds tracked by Wall St. Rank hold ORTX as of Q3 2019.

  • Credit Suisse reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Credit Suisse sold 3,550 Orchard Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $497K.
  • Credit Suisse first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 2 quarters.
  • Credit Suisse's Orchard Therapeutics plc American Depositary Shares position peaked at $497K in Q2 2019.
  • 62 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.